ERVMER34 sensitizes the response of HER2 positive breast cancer to neoadjuvant therapy

被引：0
|
作者：
Chi, Y. [1 ]
Ji, W. [1 ]
Xiu, B. [1 ]
Zhang, Q. [1 ]
Wu, J. [1 ]
机构：
[1] Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R China
来源：
CANCER RESEARCH | 2019年 / 79卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS18-P5-03-13
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P5-03-13
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Predictors of pathologic complete response in HER2 positive breast cancer patients treated with neoadjuvant targeted therapy
    Rosario, Mariela Huerta
    Sahoo, Sunati
    CANCER RESEARCH, 2020, 80 (04)
  • [22] Loss of HER2 expression in HER2-positive breast cancer patients after neoadjuvant therapy
    Sang, Yuting
    Wu, Jiong
    Yang, Benlong
    CANCER RESEARCH, 2022, 82 (04)
  • [23] Axillary Response to Neoadjuvant Therapy in Node-Positive, Estrogen Receptor Positive, HER2 Negative Breast Cancer Patients
    Friedman-Eldar, O.
    Ozmen, T.
    Reyes, F. Valle
    Goel, N.
    Tjendra, Y.
    Moller, M.
    Kesmodel, S. B.
    Franceschi, D.
    Avisar, E.
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (SUPPL 1) : S68 - S68
  • [24] Targeted therapy for HER2 positive breast cancer
    Jason A Incorvati
    Shilpan Shah
    Ying Mu
    Janice Lu
    Journal of Hematology & Oncology, 6
  • [25] Adjuvant therapy in breast cancer HER2 positive
    Olivito, V.
    De Simone, R.
    La Gattuta, G.
    Lucia, M.
    Dima, G.
    Talarico, R.
    Filippelli, G.
    ANNALS OF ONCOLOGY, 2006, 17 : VII146 - VII146
  • [26] HER2 immunohistochemistry staining positivity is strongly predictive of tumor response to neoadjuvant chemotherapy in HER2 positive breast cancer
    Zhao, Jing
    Krishnamurti, Uma
    Zhang, Chao
    Meisel, Jane
    Wei, Zhimin
    Suo, Aili
    Aneja, Ritu
    Li, Zaibo
    Li, Xiaoxian
    PATHOLOGY RESEARCH AND PRACTICE, 2020, 216 (11)
  • [27] Targeted therapy for HER2 positive breast cancer
    Incorvati, Jason A.
    Shah, Shilpan
    Mu, Ying
    Lu, Janice
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2013, 6
  • [28] Neoadjuvant chemotherapy with HER2 inhibitors for breast cancer response
    Brede-Hekimian, Katya
    LANCET, 2012, 379 (9833): : 2237 - 2237
  • [29] An Appraisal of Clinicopathologic Parameters Associated with Response to Neoadjuvant Treatment in HER2 Positive Breast Cancer
    Rong, Juan
    Hasteh, Farnaz
    Fadare, Oluwole
    Zare, Somaye
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 248 - 248
  • [30] An Appraisal of Clinicopathologic Parameters Associated with Response to Neoadjuvant Treatment in HER2 Positive Breast Cancer
    Rong, Juan
    Hasteh, Farnaz
    Fadare, Oluwole
    Zare, Somaye
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 248 - 248
12345